Agnès Le Saux-Narjoz is Managing Director of Biobank Technology Ventures LLC (USA), an early-stage life science investment company that she co-founded in 2001. She is also member of the advisory board of ELM (Luxembourg & USA), a multi-sector investment company with active participations in agro-food, alternative energies, medtech and real estate in Europe and Americas. Prior to her venture investment years, Agnès had an extensive and successful experience in managing and developing technology companies on a global basis. Among various, she was for 12 years a top executive of Genset (Nasdaq-listed genomics company) that she joined at inception. Responsible for its Product Division's worldwide commercial operations, she led the planning, financing and creation of subsidiaries in Japan, Singapore and Australia. She also devised and implemented a development strategy for its Genomics Business Unit, established relationships with major pharmaceutical groups and negotiated multi-million dollar collaborative and licensing deals in the US. Agnès holds a MSc. in Pharmaceutical Sciences. She currently sits on the board of directors of several private companies in the life science and consumer goods sectors.
BUSINESS AND MANAGEMENT